Henry Schein Inc., a leading healthcare solutions provider, has secured a $250 million investment from private equity ...

FS KKR Capital (FSK) is in focus, with the stock boasting a jaw-dropping 11.1% dividend yield, which currently leads IBD's ...

Private equity firm KKR & Co. Inc. has invested $250 million in Henry Schein Inc., Long Island’s largest publicly traded ...

Henry Schein receives $250 million strategic investment from KKR, making them largest non-index fund shareholder.

Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor ...

KKR is set to become the largest non-index fund shareholder in Henry Schein, acquiring a 12% stake through a $250 million investment.

Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and ...

Shares of KKR & Co Inc (KKR) and Henry Schein drew retail attention on Wednesday after it was revealed that the private ...

KKR & Co. has taken a 12% stake in Henry Schein Inc. and will work with the company to improve operations at the world’s ...

Private-equity firm KKR has taken a large stake in Henry Schein and plans to work with the distributor of healthcare products ...

KKR plans to announce a deal that includes increasing its stake to 12% with the option to buy up to an additional 2.9% in the ...

Centerview Partners LLC and Evercore Inc. are serving as financial advisors and Cleary Gottlieb Steen & Hamilton LLP is serving as legal advisor to Henry Schein. Kirkland & Ellis LLP is serving as ...